Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SECUKINUMAB vs SELPERCATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SECUKINUMAB vs SELPERCATINIB: Safety Overview

Metric SECUKINUMAB SELPERCATINIB
Total FAERS Reports 151,223 1,084
Deaths Reported 6,855 160
Death Rate 4.5% 14.8%
Hospitalizations 19,098 342
Average Patient Age 52.3 yrs 63.0 yrs
% Female Patients 61.9% 56.7%
FDA Approval Date N/A Apr 10, 2024
Manufacturer Novartis Pharmaceuticals Corporation Eli Lilly and Company
Route SUBCUTANEOUS ORAL
Marketing Status Prescription Prescription